Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide

Clinical Microbiology and Infection

Volumn 17, Issue 12, 2011, Pages 1792-1797

  Ghiraldi, L D ^a   Campanerut, P A Z ^a   Spositto, F L E ^a   Sato, D N ^b   Leite, C Q F ^c   Hirata, M ^d   Hirata, R D C ^d   Cardoso, R F ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Microscopic observation drug susceptibility assay (MODS); Pyrazinamide; Resistance; Susceptibility testing; Tuberculosis

Indexed keywords

AMIDASE; PYRAZINAMIDASE; PYRAZINAMIDE; UNCLASSIFIED DRUG;

ABSOLUTE CONCENTRATION METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BIOASSAY; BROTH DILUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE MUTATION; INTERMETHOD COMPARISON; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STRAIN DIFFERENCE;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 81255152081     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03508.x     Document Type: Article

References (28)

1. World Health Organization. Global tuberculosis control-surveillance, planning, financing. 2009; WHO/HTM/TB/2009.411.
2. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003; 7: 6-21.
3. Hu Y, Coates AR, Mitchison DA. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2006; 10: 317-322.
4. Cutler RR, Wilson P, Villarroel J, Clarke FV. Evaluating current methods for determination of the susceptibility of mycobacteria to pyrazinamide, conventional, radiometric Bactec and two methods of pyrazinamidase testing. Lett Appl Microbiol 1997; 24: 127-132.
5. Kent PT, Kubica GP. Public health mycobacteriology. A guide for the level III laboratory. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1985.
6. Palomino JC, Martin A, Groll AV, Portaels F. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. J Microbiol Methods 2008; 75: 161-166.
7. Kumar M, Khan IA, Verna V, Kalyan N, Qazi GN. Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay. Diagn Microbiol Infect Dis 2005; 53: 121-124.
8. Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002; 46: 2720-2722.
9. Franzblau SG, Witzig RS, McLaughlin JC et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar blue assay. J Clin Microbiol 1998; 36: 362-366.
10. Foongladda S, Roengsanthia D, Arjrattanakool W, Chuchottaworn C, Chaiprasert A, Franzblau SG. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002; 6: 1118-1122.
11. Leite CQF, Beretta ALRZ, Anno IS, Telles MAS. Standardization of broth microdilution method for Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2000; 95: 127-129.
12. Caviedes L, Lee TS, Gilman RH et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208.
13. Moore DA, Mendoza D, Gilman RH et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42: 4432-4437.
14. Caviedes L, Moore DAJ. Introducing MODS: a low-cost, low-tech tool for high performance detection of tuberculosis and multidrug resistant tuberculosis. Indian J Med Microbiol 2007; 25: 87-88.
15. Mello FCQ, Arias MS, Rosales S et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol 2007; 45: 3387-3389.
16. Mengatto L, Chiani Y, Imaz MS. Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2006; 101: 535-542.
17. Shiferaw G, Woldeamanuel Y, Geneyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1093-1097.
18. Ministério da Saúde. Fundação Nacional da Saúde. Manual de bacteriologia da tuberculose. Centro de referência professor Helio Fraga, 2nd edn. Brasil: Rio de Janeiro, 1994; 135-150.
19. Barco P, Cardoso RF, Hirata RDC et al. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J Antimicrob Chemother 2006; 58: 930-935.
20. Syre A, Øvreas K, Grewal HMS. Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay. J Antimicrob Chemother 2010; 65: 704-712.
21. Singh P, Wesley C, Jadaun GPS et al. Comparative evaluation of Lowenstein-Jensen proportion method BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 76-80.
22. Huang T, Lee SS, Tu H et al. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob Agents Chemother 2003; 47: 3672-3673.
23. Morlock GP, Crawford JT, Butler R et al. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 2291-2295.
24. Doustdar F, Khosravi AD, Farnia P. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran. Microb Drug Resist 2009; 15: 251-256.
25. Cardoso RF, Cooksey RC, Morlock GP et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004; 48: 3373-3381.
26. Jureen P, Wernfren J, Toro JC, Hoffner S. Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2008; 52: 1852-1854.
27. Sheen P, Ferrer P, Gilman RH et al. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis 2009; 89: 109-113.
28. Krishnamurthy A, Almeida D, Rodrigues C, Mehta A. Comparison of pyrazinamide drug susceptibility of Mycobacterium tuberculosis by radiometric BACTEC and enzymatic pyrazinamidase assay. Indian J Med Microbiol 2004; 22: 166-168.